Addex Therapeutics (ADXN)
(Delayed Data from NSDQ)
$8.13 USD
+0.03 (0.37%)
Updated Aug 4, 2025 10:00 AM ET
After-Market: $8.51 +0.38 (4.67%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Addex Therapeutics Ltd. Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ADXN 8.13 +0.03(0.37%)
Will ADXN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADXN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADXN
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?
ADXN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Other News for ADXN
Addex Therapeutics (ADXN) Invests in Stalicla's Autism Drug Development
Stalicla secures CHF 2M investment led by Addex for neuropsychiatric drug development
Addex Therapeutics Secures Shareholder Approval at 2025 AGM
Trading Resumes for Addex Therapeutics (ADXN) | ADXN Stock News
Addex Therapeutics Ltd – ADR trading resumes